CRM earnings: next report 2026-09-02, real EPS beat/miss history, analyst consensus Buy, P/E 18.80. Updated 2026-07-23.
Salesforce (CRM) Research Hub
Salesforce (CRM) trades on NYSE, US in the Technology (Software - Application) sector. As of 2026-09-11, shares last closed at 247.72 USD (+1.46%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 18.80, market cap 134.14B. This hub links to the full technical, earnings and options research available for CRM.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Technology (Software - Application) |
|---|---|
| Exchange | NYSE, US |
| Last close | 247.72 USD (+1.46%) |
| 52-week range | 146.32 USD – 268.27 USD |
| Trend regime | Range |
| 14-day RSI | 72.3 (Overbought) |
| Trailing P/E | 18.80 |
| Market cap | 134.14B |
| Dividend yield | 1.05% |
| Next earnings | 2026-09-02 |
Available research for CRM
Covered Call on CRM: how it works, illustrative setup around the real 247.72 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CRM: how it works, illustrative setup around the real 247.72 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CRM: how it works, illustrative setup around the real 247.72 USD price, max profit/loss, breakeven and when to use it. Educational.
CRM technical analysis: range, last 247.72 USD, RSI 72.3, 52w range 146.32 USD–268.27 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CRM in?
Salesforce (CRM) is classified under Technology (Software - Application), listed on NYSE, US.
Is CRM in an uptrend or downtrend?
As of 2026-09-11, CRM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CRM's trailing P/E ratio?
CRM's trailing P/E is 18.80, with a market cap of 134.14B. See the earnings research page for full valuation detail.
When does CRM next report earnings?
CRM is next scheduled to report earnings on 2026-09-02, with a consensus EPS estimate of 3.27 USD.